Mereo BioPharma Group PLC (MREO)
3.11
-0.04
(-1.27%)
USD |
NASDAQ |
May 02, 16:00
3.115
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Debt to Equity Ratio: 0.0869 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0869 |
| June 30, 2023 | 0.136 |
| December 31, 2022 | 0.2593 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.2292 |
| December 31, 2021 | 0.1635 |
| June 30, 2021 | 0.2223 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0869
Minimum
Dec 2023
0.2593
Maximum
Dec 2022
0.1829
Average
0.1929
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 66.50M |
| Total Liabilities (Quarterly) | 15.96M |
| Shareholders Equity (Quarterly) | 50.54M |
| Current Ratio | 6.722 |
| Net Debt Paydown Yield | 1.54% |